Individual psychomotor impairment in relation to zopiclone and ethanol concentrations in blood - A randomized controlled double-blinded trial

Addiction

Volumn 107, Issue 5, 2012, Pages 925-932

  Gustavsen, Ingebjørg ^a   Hjelmeland, Knut ^a,b   Bernard, Jean Paul ^a,b   Mørland, Jørg ^a,c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute tolerance; Ethanol; Impairment; Psychomotor performance; Randomized controlled trial; Zopiclone

Indexed keywords

ALCOHOL; AZABICYCLO DERIVATIVE; HYPNOTIC SEDATIVE AGENT; PIPERAZINE DERIVATIVE; ZOPICLONE;

ARTICLE; BLOOD; CAR DRIVING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; MALE; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL;

AUTOMOBILE DRIVING; AZABICYCLO COMPOUNDS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ETHANOL; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PIPERAZINES; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE;

EID: 84859436087     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03693.x     Document Type: Article

References (24)

1. Schnabel E., Hargutt V., Krüger H. Meta-analysis of empirical studies concerning the effects of alcohol on safe driving. University of Wuerzburg; 2010 August 14. 1.
2. Hiltunen A. J. Acute alcohol tolerance in cognitive and psychomotor performance: influence of the alcohol dose and prior alcohol experience. Alcohol 1997; 14: 125-30.
3. Blomberg R. D., Peck R. C., Moskowitz H., Burns M., Fiorentino D. The Long Beach/Fort Lauderdale relative risk study. J Safety Res 2009; 40: 285-92.
4. Ogden E. J., Moskowitz H. Effects of alcohol and other drugs on driver performance. Traffic Inj Prev 2004; 5: 185-98.
5. Mørland J. Driving under the influence of non-alcohol drugs. Forensic Sci Rev 2000; 12: 80-105.
6. Engeland A., Skurtveit S., Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 2007; 17: 597-602.
7. Longo M. C., Hunter C. E., Lokan R. J., White J. M., White M. A. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part II: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000; 32: 623-32.
8. Grotenhermen F., Leson G., Berghaus G., Drummer O. H., Kruger H. P., Longo M. etal. Developing limits for driving under cannabis. Addiction 2007; 102: 1910-7.
9. Ramaekers J. G., Moeller M. R., van R. P., Theunissen E. L., Schneider E., Kauert G. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 2006; 85: 114-22.
10. Ellinwood E. H. Jr, Nikaido A. M., Heatherly D. G., Bjornsson T. D. Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms. Psychopharmacology (Berl) 1987; 91: 168-74.
11. Ingum J., Bjorklund R., Volden R., Morland J. Development of acute tolerance after oral doses of diazepam and flunitrazepam. Psychopharmacology (Berl) 1994; 113: 304-10.
12. dos Santos F. M., Goncalves J. C., Caminha R., da Silveira G. E., Neves C. S., Gram K. R. etal. Pharmacokinetic/pharmacodynamic modeling of psychomotor impairment induced by oral clonazepam in healthy volunteers. Ther Drug Monit 2009; 31: 566-74.
13. Walsh J. M., Verstraete A. G., Huestis M. A., Morland J. Guidelines for research on drugged driving. Addiction 2008; 103: 1258-68.
14. Gustavsen I., Bramness J. G., Skurtveit S., Engeland A., Neutel I., Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9: 818-22.
15. Gustavsen I., Hjelmeland K., Bernard J. P., Morland J. Psychomotor performance after intake of zopiclone compared to intake of ethanol-a randomized controlled double-blinded trial. J Clin Psychopharmacol 2011; 31: 481-8.
16. Leufkens T. R., Vermeeren A. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20mg, zopiclone 7.5mg, and placebo. J Clin Psychopharmacol 2009; 29: 432-8.
17. Vermeeren A., Riedel W. J., van Boxtel M. P., Darwish M., Paty I., Patat A. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 2002; 25: 224-31.
18. Verster J. C., Veldhuijzen D. S., Volkerts E. R. Residual effects of sleep medication on driving ability. Sleep Med Rev 2004; 8: 309-25.
19. Kuitunen T., Mattila M. J., Seppala T., Aranko K., Mattila M. E. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. Br J Clin Pharmacol 1990; 30: 453-61.
20. Mattila M. J., Mattila-Evenden M. E. Effects of alcohol and hypnosedative drugs on digit-symbol substitution: comparison of two different computerized tests. J Psychopharmacol 1997; 11: 313-7.
21. Kuitunen T. Drug and ethanol effects on the clinical test for drunkenness: single doses of ethanol, hypnotic drugs and antidepressant drugs. Pharmacol Toxicol 1994; 75: 91-8.
22. Gjerde H., Oiestad E. L., Oiestad A. M., Langodegard M., Gustavsen I., Hjelmeland K. etal. Comparison of zopiclone concentrations in oral fluid sampled with Intercept(®) oral specimen collection device and Statsure Saliva Sampler and concentrations in blood. J Anal Toxicol 2010; 34: 590-3.
23. Kristoffersen L., Stormyhr L. E., Smith-Kielland A. Headspace gas chromatographic determination of ethanol: the use of factorial design to study effects of blood storage and headspace conditions on ethanol stability and acetaldehyde formation in whole blood and plasma. Forensic Sci Int 2006; 161: 151-7.
24. Gustavsen I., Al-Sammurraie M., Mørland J., Bramness J. G. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev 2009; 41: 462-6. [correction added after online publication 14 March 2012: duplication of reference amended]